Skip to main content
. 2019 Jun 27;3(2):e190–e199. doi: 10.1055/s-0039-1688414

Table 2. Summary of mean total Pettersson score, HJHS, and global gait assessment (HJHS) a .

Pediatric (6–18 y) Adult (>18 y)
Without inhibitors
( n =  104)
With inhibitors
( n =  24)
Without inhibitors
( n =  128)
With inhibitors
( n =  26)
Total
( N  = 282)
Observed Pettersson score, mean (SD) ( n  = 85)
12.3 (13.3)
( n  = 20)
14.2 (19.6)
( n  = 104)
17.0 (12.6)
( n  = 19)
16.8 (9.7)
( n  = 228)
15.0 (13.5)
Total HJHS, mean (SD) ( n  = 102)
15.2 (12.2)
( n  = 23)
10.9 (13.0)
( n  = 127)
20.8 (13.1)
( n  = 26)
20.2 (9.1)
( n  = 278)
17.9 (12.8)
Skills not within normal limits, n (%)
 0 47 (45.2) 15 (62.5) 20 (15.6) 3 (11.5) 85 (30.1)
 1 20 (19.2) 4 (16.7) 28 (21.9) 7 (26.9) 59 (20.9)
 2 22 (21.2) 1 (4.2) 37 (28.9) 7 (26.9) 67 (23.8)
 3 7 (6.7) 1 (4.2) 21 (16.4) 5 (19.2) 34 (12.1)
 4 5 (4.8) 1 (4.2) 20 (15.6) 4 (15.4) 30 (10.6)
 Not applicable/missing 3 (2.9) 2 (8.3) 2 (1.6) 0 7 (2.5)

Abbreviations: HJHS, Hemophilia Joint Health Score; SD, standard deviation.

a

Pettersson score, HJHS total, and HJHS global gait score were not reported by physicians for all patients.